Status:
COMPLETED
Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary Objectives: * To compare the effectiveness of an interactive voice response (IVR) telephone triage/feedback system versus an interactive voice response telephone system with assessment only i...
Detailed Description
You will be asked to complete several questionnaires during a visit to the Thoracic Clinic. These questionnaires measure physical and emotional symptoms, and quality of life. Completing the questionna...
Eligibility Criteria
Inclusion
- Patients diagnosed with stage III or IV non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) (Patients who have received other prior chemotherapy are eligible.)
- 18 years of age or older
- English-speaking
- Lives in the United States
- Adequate vision and hearing to use the Interactive Voice Response (IVR) system
- Provides written informed consent
Exclusion
- Current diagnosis of psychosis or dementia
- Patients unable to complete the assessment measures or unable to understand the purpose of the study
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00423436
Start Date
April 1 2003
End Date
February 1 2011
Last Update
December 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030